Project Description

Luoda has developed a combination product with antibacterial, antifungal and anti-inflammatory activity which is administered as a single long acting application into the canine external ear canal under light sedation by a veterinarian. This eliminates the need for application to the ear 2-3 times a day, increasing the likelihood of therapeutic success in this notoriously difficult to treat condition.


Otitis externa (infection of the external ear canal) in dogs

Project Details

Development Status: Clinical Development Ongoing
Licence Status: Pharma company partner being sought
Commercialisation Date: Estimated 2019